PubMed

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics and outcome from the large randomised prospective trial (UKALL XII/ECOG 2993).

Marks DI, Paietta EM, Moorman AV, Richards SM, Buck G, Dewald G, Ferrando A, Fielding AK, Goldstone AH, Ketterling RP, Litzow MR, Luger SM, McMillan AK, Mansour M, Rowe JM, Tallman MS, Lazarus HM.

Blood. 2009 Oct 14. [Epub ahead of print]PMID: 19828704 [PubMed - as supplied by publisher]Related articles

Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group.

Litzow MR, Othus M, Cripe LD, Gore SD, Lazarus HM, Lee SJ, Bennett JM, Paietta EM, Dewald GW, Rowe JM, Tallman MS; for the Eastern Cooperative Oncology Group Leukemia Committee.

Br J Haematol. 2009 Oct 5. [Epub ahead of print]PMID: 19804455 [PubMed - as supplied by publisher]Related articles

Anthracycline dose intensification in acute myeloid leukemia.

Fernandez HF, Sun Z, Yao X, Litzow MR, Luger SM, Paietta EM, Racevskis J, Dewald GW, Ketterling RP, Bennett JM, Rowe JM, Lazarus HM, Tallman MS.

N Engl J Med. 2009 Sep 24;361(13):1249-59.PMID: 19776406 [PubMed - indexed for MEDLINE]Related articles

Complete resolution of leukemia cutis with sorafenib in an acute myeloid leukemia patient with FLT3-ITD mutation.

Lee SH, Paietta E, Racevskis J, Wiernik PH.

Am J Hematol. 2009 Oct;84(10):701-2. No abstract available. PMID: 19714594 [PubMed - in process]Related articles

A pilot study of carboplatin and mitoxantrone in blast crisis of chronic myeloid leukemia.

Dutcher JP, Morris EL, Gaynor B, Paietta E, Wiernik PH.

Med Oncol. 2009 Aug 21. [Epub ahead of print]PMID: 19697165 [PubMed - as supplied by publisher]Related articles

Mutational analysis of candidate tumor-associated genes in acute megakaryoblastic leukemia.

Bhat R, Malinge S, Gamis AS, Sorrell AD, Hilden JM, Ketterling RP, Paietta E, Tallman MS, Crispino JD.

Leukemia. 2009 Nov;23(11):2159-60. Epub 2009 Aug 6. No abstract available. PMID: 19657363 [PubMed - in process]Related articles

MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.

Figueroa ME, Skrabanek L, Li Y, Jiemjit A, Fandy TE, Paietta E, Fernandez H, Tallman MS, Greally JM, Carraway H, Licht JD, Gore SD, Melnick A.

Blood. 2009 Oct 15;114(16):3448-58. Epub 2009 Aug 3.PMID: 19652201 [PubMed - indexed for MEDLINE]Related articles

Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.

Mansour MR, Sulis ML, Duke V, Foroni L, Jenkinson S, Koo K, Allen CG, Gale RE, Buck G, Richards S, Paietta E, Rowe JM, Tallman MS, Goldstone AH, Ferrando AA, Linch DC.

J Clin Oncol. 2009 Sep 10;27(26):4352-6. Epub 2009 Jul 27.PMID: 19635999 [PubMed - indexed for MEDLINE]Related articles

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).

Greenberg PL, Sun Z, Miller KB, Bennett JM, Tallman MS, Dewald G, Paietta E, van der Jagt R, Houston J, Thomas ML, Cella D, Rowe JM.

Blood. 2009 Sep 17;114(12):2393-400. Epub 2009 Jun 29.PMID: 19564636 [PubMed - indexed for MEDLINE]Related articles

Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.

Lee SH, Abebe L, Paietta E, Einzig A, Wiernik PH.

Am J Hematol. 2009 Jul;84(7):455-7. Review. No abstract available. PMID: 19507211 [PubMed - indexed for MEDLINE]Related articles

WT1 mutations in T-ALL.

Tosello V, Mansour MR, Barnes K, Paganin M, Sulis ML, Jenkinson S, Allen CG, Gale RE, Linch DC, Palomero T, Real P, Murty V, Yao X, Richards SM, Goldstone A, Rowe J, Basso G, Wiernik PH, Paietta E, Pieters R, Horstmann M, Meijerink JP, Ferrando AA.

Blood. 2009 Jul 30;114(5):1038-45. Epub 2009 Jun 3.PMID: 19494353 [PubMed - indexed for MEDLINE]Related articles

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.

Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, Huberman K, Thomas S, Dolgalev I, Heguy A, Paietta E, Le Beau MM, Beran M, Tallman MS, Ebert BL, Kantarjian HM, Stone RM, Gilliland DG, Crispino JD, Levine RL.

Blood. 2009 Jul 2;114(1):144-7. Epub 2009 May 6.PMID: 19420352 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.

Fielding AK, Rowe JM, Richards SM, Buck G, Moorman AV, Durrant IJ, Marks DI, McMillan AK, Litzow MR, Lazarus HM, Foroni L, Dewald G, Franklin IM, Luger SM, Paietta E, Wiernik PH, Tallman MS, Goldstone AH.

Blood. 2009 May 7;113(19):4489-96. Epub 2009 Feb 24.PMID: 19244158 [PubMed - indexed for MEDLINE]Related articles

An integrative genomic and epigenomic approach for the study of transcriptional regulation.

Figueroa ME, Reimers M, Thompson RF, Ye K, Li Y, Selzer RR, Fridriksson J, Paietta E, Wiernik P, Green RD, Greally JM, Melnick A.

PLoS One. 2008 Mar 26;3(3):e1882.PMID: 18365023 [PubMed - indexed for MEDLINE]Related articlesFree article

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).

Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK, Burnett AK, Chopra R, Wiernik PH, Foroni L, Paietta E, Litzow MR, Marks DI, Durrant J, McMillan A, Franklin IM, Luger S, Ciobanu N, Rowe JM.

Blood. 2008 Feb 15;111(4):1827-33. Epub 2007 Nov 29.PMID: 18048644 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.

Juric D, Lacayo NJ, Ramsey MC, Racevskis J, Wiernik PH, Rowe JM, Goldstone AH, O'Dwyer PJ, Paietta E, Sikic BI.

J Clin Oncol. 2007 Apr 10;25(11):1341-9. Epub 2007 Feb 20.PMID: 17312329 [PubMed - indexed for MEDLINE]Related articles

Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.

Flinn IW, Neuberg DS, Grever MR, Dewald GW, Bennett JM, Paietta EM, Hussein MA, Appelbaum FR, Larson RA, Moore DF Jr, Tallman MS.

J Clin Oncol. 2007 Mar 1;25(7):793-8. Epub 2007 Feb 5.PMID: 17283364 [PubMed - indexed for MEDLINE]Related articles

Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.

Grever MR, Lucas DM, Dewald GW, Neuberg DS, Reed JC, Kitada S, Flinn IW, Tallman MS, Appelbaum FR, Larson RA, Paietta E, Jelinek DF, Gribben JG, Byrd JC.

J Clin Oncol. 2007 Mar 1;25(7):799-804. Epub 2007 Feb 5.PMID: 17283363 [PubMed - indexed for MEDLINE]Related articles

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.

Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M, Vance GH, Cherry AM, Higgins RR, Fielding AK, Foroni L, Paietta E, Tallman MS, Litzow MR, Wiernik PH, Rowe JM, Goldstone AH, Dewald GW; Adult Leukaemia Working Party, Medical Research Council/National Cancer Research Institute.

Blood. 2007 Apr 15;109(8):3189-97. Epub 2006 Dec 14.PMID: 17170120 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.

Litzow MR, Lee S, Bennett JM, Dewald GW, Gallagher RE, Jain V, Paietta EM, Racevskis J, Rousey SR, Mazza JJ, Tallman MS.

Haematologica. 2006 Aug;91(8):1105-8. Epub 2006 Jul 25.PMID: 16870552 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997.

Cripe LD, Rader K, Tallman MS, Gordon MS, Paietta E, Bennett J, Neuberg D, Litzow MR, O'brien TE, Rowe JM.

Leuk Res. 2006 Jul;30(7):823-7. Epub 2006 Jan 18.PMID: 16413056 [PubMed - indexed for MEDLINE]Related articles

Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia.

Sweetser DA, Peniket AJ, Haaland C, Blomberg AA, Zhang Y, Zaidi ST, Dayyani F, Zhao Z, Heerema NA, Boultwood J, Dewald GW, Paietta E, Slovak ML, Willman CL, Wainscoat JS, Bernstein ID, Daly SB.

Genes Chromosomes Cancer. 2005 Nov;44(3):279-91.PMID: 16015647 [PubMed - indexed for MEDLINE]Related articles

Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).

Dutcher JP, Lee S, Gallagher RE, Makary AZ, Hines JD, Londer H, Farnen JP, Bennett JM, Paietta E, Rowe JM, Goloubeva O, Wiernik PH; Eastern Cooperative Oncology Group.

Leuk Lymphoma. 2005 Mar;46(3):377-85.PMID: 15621827 [PubMed - indexed for MEDLINE]Related articles

Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).

Cassileth PA, Lee SJ, Litzow MR, Miller KB, Stadtmauer EA, Tallman MS, Lazarus HM, Bennett JM, Paietta E, Dewald GW, Rowe JM; Eastern Cooperative Oncology Group.

Leuk Lymphoma. 2005 Jan;46(1):55-61.PMID: 15621781 [PubMed - indexed for MEDLINE]Related articles

Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia.

Karbasian-Esfahani M, Wiernik PH, Novik Y, Paietta E, Dutcher JP.

Cancer. 2004 Sep 15;101(6):1414-9.PMID: 15368329 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998).

Wiernik PH, Paietta E, Goloubeva O, Lee SJ, Makower D, Bennett JM, Wade JL, Ghosh C, Kaminer LS, Pizzolo J, Tallman MS; Eastern Cooperative Oncology Group.

Leukemia. 2004 Oct;18(10):1605-10.PMID: 15356646 [PubMed - indexed for MEDLINE]Related articles

Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.

Tallman MS, Lefèbvre P, Baine RM, Shoji M, Cohen I, Green D, Kwaan HC, Paietta E, Rickles FR.

J Thromb Haemost. 2004 Aug;2(8):1341-50.PMID: 15304040 [PubMed - indexed for MEDLINE]Related articles

Modified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): a trial of the Eastern Cooperative Oncology Group.

Friedenberg WR, Tallman MS, Brodsky I, Paietta E, Rowe JM, Lee SJ, Rowland KM Jr, Schnetzer GW, Reed JC.

Leuk Res. 2004 Aug;28(8):813-9.PMID: 15203279 [PubMed - indexed for MEDLINE]Related articles

Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide.

Sun Y, Kim SH, Zhou DC, Ding W, Paietta E, Guidez F, Zelent A, Ramesh KH, Cannizzaro L, Warrell RP, Gallagher RE.

Leukemia. 2004 Jul;18(7):1258-69.PMID: 15116119 [PubMed - indexed for MEDLINE]Related articles

A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.

Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS; Eastern Cooperative Oncology Group.

Cytometry B Clin Cytom. 2004 May;59(1):1-9.PMID: 15108165 [PubMed - indexed for MEDLINE]Related articlesFree article

Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias.

Paietta E, Ferrando AA, Neuberg D, Bennett JM, Racevskis J, Lazarus H, Dewald G, Rowe JM, Wiernik PH, Tallman MS, Look AT.

Blood. 2004 Jul 15;104(2):558-60. Epub 2004 Mar 25.PMID: 15044257 [PubMed - indexed for MEDLINE]Related articlesFree article

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).

Greenberg PL, Lee SJ, Advani R, Tallman MS, Sikic BI, Letendre L, Dugan K, Lum B, Chin DL, Dewald G, Paietta E, Bennett JM, Rowe JM.

J Clin Oncol. 2004 Mar 15;22(6):1078-86. Erratum in: J Clin Oncol. 2004 Jul 1;22(13):2747. PMID: 15020609 [PubMed - indexed for MEDLINE]Related articles

Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.

Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH, Rowe JM, Caligiuri MA, Bloomfield CD, Look AT.

Lancet. 2004 Feb 14;363(9408):535-6.PMID: 14975618 [PubMed - indexed for MEDLINE]Related articles

Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.

Tallman MS, Kim HT, Paietta E, Bennett JM, Dewald G, Cassileth PA, Wiernik PH, Rowe JM; Eastern Cooperative Oncology Group.

J Clin Oncol. 2004 Apr 1;22(7):1276-86. Epub 2004 Feb 17.PMID: 14970186 [PubMed - indexed for MEDLINE]Related articles

How to optimize multiparameter flow cytometry for leukaemia/lymphoma diagnosis.

Paietta E.

Best Pract Res Clin Haematol. 2003 Dec;16(4):671-83.PMID: 14592650 [PubMed - indexed for MEDLINE]Related articles

Comments on the 2001 WHO proposal for the classification of haematopoietic neoplasms.

Paietta E.

Best Pract Res Clin Haematol. 2003 Dec;16(4):547-59.PMID: 14592642 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).

Wiernik PH, Cassileth PA, Leong T, Hoagland HC, Bennett JM, Paietta E, Oken MM; Eastern Cooperative Oncology Group Study.

Leuk Lymphoma. 2003 Sep;44(9):1515-21.PMID: 14565653 [PubMed - indexed for MEDLINE]Related articles

A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.

Rowe JM, Neuberg D, Friedenberg W, Bennett JM, Paietta E, Makary AZ, Liesveld JL, Abboud CN, Dewald G, Hayes FA, Tallman MS, Wiernik PH; Eastern Cooperative Oncology.

Blood. 2004 Jan 15;103(2):479-85. Epub 2003 Sep 25.PMID: 14512295 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of cell-surface antigens in acute promyelocytic leukaemia.

Paietta E.

Best Pract Res Clin Haematol. 2003 Sep;16(3):369-85. Review.PMID: 12935957 [PubMed - indexed for MEDLINE]Related articles

Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials.

Paietta E, Neuberg D, Bennett JM, Dewald G, Rowe JM, Cassileth PA, Cripe L, Tallman MS, Wiernik PH; Eastern Cooperative Oncology Group.

Leukemia. 2003 Aug;17(8):1544-50.PMID: 12886241 [PubMed - indexed for MEDLINE]Related articles

Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer.

Tallman MS, Gray R, Robert NJ, LeMaistre CF, Osborne CK, Vaughan WP, Gradishar WJ, Pisansky TM, Fetting J, Paietta E, Lazarus HM.

N Engl J Med. 2003 Jul 3;349(1):17-26.PMID: 12840088 [PubMed - indexed for MEDLINE]Related articlesFree article

Assessing minimal residual disease (MRD) in leukemia: a changing definition and concept?

Paietta E.

Bone Marrow Transplant. 2002 Mar;29(6):459-65. Review.PMID: 11960263 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.

Bennett JM, Young MS, Liesveld JL, Paietta E, Miller KB, Lazarus HM, Marsh RD, Friedenberg WR, Saba HT, Hayes FA, Dewald GW, Hiddemann W, Rowe JM.

Am J Hematol. 2001 Jan;66(1):23-7.PMID: 11426487 [PubMed - indexed for MEDLINE]Related articles

Anticipation in familial chronic lymphocytic leukaemia.

Wiernik PH, Ashwin M, Hu XP, Paietta E, Brown K.

Br J Haematol. 2001 May;113(2):407-14.PMID: 11380406 [PubMed - indexed for MEDLINE]Related articles

Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity.

Paietta E, Neuberg D, Richards S, Bennett JM, Han L, Racevskis J, Dewald G, Rowe JM, Wiernik PH; Eastern Cooperative Oncology Group.

Am J Hematol. 2001 Mar;66(3):189-96.PMID: 11279625 [PubMed - indexed for MEDLINE]Related articles

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ, Appelbaum FR.

Blood. 2000 Dec 15;96(13):4075-83.PMID: 11110676 [PubMed - indexed for MEDLINE]Related articlesFree article

Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience.

Tallman MS, Neuberg D, Bennett JM, Francois CJ, Paietta E, Wiernik PH, Dewald G, Cassileth PA, Oken MM, Rowe JM.

Blood. 2000 Oct 1;96(7):2405-11.PMID: 11001891 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995.

Gordon MS, Young ML, Tallman MS, Cripe LD, Bennett JM, Paietta E, Longo W, Gerad H, Mazza J, Rowe JM.

Leuk Res. 2000 Oct;24(10):871-5.PMID: 10996206 [PubMed - indexed for MEDLINE]Related articles

Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma.

Wiernik PH, Wang SQ, Hu XP, Marino P, Paietta E.

Br J Haematol. 2000 Jan;108(1):72-9.PMID: 10651726 [PubMed - indexed for MEDLINE]Related articles

Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC).

Advani R, Visani G, Milligan D, Saba H, Tallman M, Rowe JM, Wiernik PH, Ramek J, Dugan K, Lum B, Villena J, Davis E, Paietta E, Litchman M, Covelli A, Sikic B, Greenberg P.

Adv Exp Med Biol. 1999;457:47-56.PMID: 10500779 [PubMed - indexed for MEDLINE]Related articles